Summit Therapeutics Options Trading: A Deep Dive Into Market Sentiment
Summit Therapeutics Options Trading: A Deep Dive Into Market Sentiment
In terms of liquidity and interest, the mean open interest for Summit Therapeutics options trades today is 1076.55 with a total volume of 2,794.00.Financial giants have made a conspicuous bullish move on Summit Therapeutics. Our analysis of options history for Summit Therapeutics (NASDAQ:SMMT) revealed 13 unusual trades.
金融巨頭對Summit Therapeutics採取了明顯的看漲舉動。我們對Summit Therapeutics（納斯達克股票代碼：SMMT）期權歷史的分析顯示了13筆不尋常的交易。
Delving into the details, we found 38% of traders were bullish, while 38% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $142,500, and 10 were calls, valued at $863,755.
深入研究細節，我們發現38％的交易者看漲，而38％的交易者表現出看跌趨勢。在我們發現的所有交易中，有3筆是看跌期權，價值爲142,500美元，10筆是看漲期權，價值863,755美元。
Expected Price Movements
預期的價格走勢
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $14.0 to $30.0 for Summit Therapeutics over the recent three months.
根據交易活動，看來主要投資者的目標是在最近三個月中將Summit Therapeutics的價格區間從14.0美元擴大到30.0美元。
Volume & Open Interest Trends
交易量和未平倉合約趨勢
In terms of liquidity and interest, the mean open interest for Summit Therapeutics options trades today is 1076.55 with a total volume of 2,794.00.
就流動性和利息而言，Summit Therapeutics期權交易的平均未平倉合約爲1076.55，總交易量爲2794.00。
In the following chart, we are able to follow the development of volume and open interest of call and put options for Summit Therapeutics's big money trades within a strike price range of $14.0 to $30.0 over the last 30 days.
在下圖中，我們可以跟蹤過去30天Summit Therapeutics在14.0美元至30.0美元行使價區間內的大額資金交易的看漲期權和未平倉合約的變化。
Summit Therapeutics Option Activity Analysis: Last 30 Days
Summit Therapeutics期權活動分析：過去 30 天
Significant Options Trades Detected:
檢測到的重要期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SMMT | CALL | TRADE | BULLISH | 09/20/24 | $9.9 | $9.1 | $9.6 | $14.00 | $287.0K | 3.9K | 502 |
| SMMT | CALL | TRADE | NEUTRAL | 09/20/24 | $9.3 | $8.4 | $8.9 | $14.00 | $178.0K | 3.9K | 202 |
| SMMT | CALL | SWEEP | BULLISH | 09/20/24 | $5.1 | $4.6 | $5.0 | $19.00 | $133.0K | 515 | 281 |
| SMMT | CALL | TRADE | BEARISH | 01/17/25 | $4.7 | $4.5 | $4.5 | $25.00 | $90.0K | 375 | 34 |
| SMMT | PUT | TRADE | BEARISH | 01/17/25 | $5.5 | $5.3 | $5.5 | $25.00 | $82.5K | 91 | 210 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SMMT | 打電話 | 貿易 | 看漲 | 09/20/24 | 9.9 美元 | 9.1 美元 | 9.6 美元 | 14.00 美元 | 287.0 萬美元 | 3.9K | 502 |
| SMMT | 打電話 | 貿易 | 中立 | 09/20/24 | 9.3 美元 | 8.4 美元 | 8.9 美元 | 14.00 美元 | 178.0 萬美元 | 3.9K | 202 |
| SMMT | 打電話 | 掃 | 看漲 | 09/20/24 | 5.1 美元 | 4.6 美元 | 5.0 美元 | 19.00 美元 | 133.0 萬美元 | 515 | 281 |
| SMMT | 打電話 | 貿易 | 粗魯的 | 01/17/25 | 4.7 美元 | 4.5 美元 | 4.5 美元 | 25.00 美元 | 90.0K | 375 | 34 |
| SMMT | 放 | 貿易 | 粗魯的 | 01/17/25 | 5.5 美元 | 5.3 美元 | 5.5 美元 | 25.00 美元 | 82.5 萬美元 | 91 | 210 |
About Summit Therapeutics
關於峯會療法
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Summit Therapeutics Inc是一家生物製藥公司，專注於治療嚴重傳染病的新型抗生素的發現、開發和商業化。其CDI（艱難梭菌感染）候選產品是利地尼拉唑，一種口服給藥的小分子抗生素。它有兩個地理區域：美國和英國。
Current Position of Summit Therapeutics
峯會療法目前的立場
- With a volume of 6,406,733, the price of SMMT is up 1.87% at $23.4.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 55 days.
- smMT的交易量爲6,406,733美元，上漲了1.87％，至23.4美元。
- RSI 指標暗示標的股票可能處於超買狀態。
- 下一份業績預計將在55天后公佈。
Professional Analyst Ratings for Summit Therapeutics
峯會療法專業分析師評級
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $18.4.
在過去的一個月中，5位行業分析師分享了他們對該股的見解，提出平均目標價爲18.4美元。
- An analyst from HC Wainwright & Co. downgraded its action to Buy with a price target of $16.
- An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $16.
- An analyst from Citigroup has decided to maintain their Buy rating on Summit Therapeutics, which currently sits at a price target of $19.
- An analyst from Stifel has decided to maintain their Buy rating on Summit Therapeutics, which currently sits at a price target of $25.
- An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $16.
- HC Wainwright & Co. 的一位分析師將其評級下調至買入，目標股價爲16美元。
- HC Wainwright & Co. 的一位分析師已將其評級下調至買入，將目標股價調整爲16美元。
- 花旗集團的一位分析師已決定維持對Summit Therapeutics的買入評級，該評級目前的目標股價爲19美元。
- Stifel的一位分析師已決定維持對Summit Therapeutics的買入評級，該評級目前的目標股價爲25美元。
- HC Wainwright & Co. 的一位分析師已將其評級下調至買入，將目標股價調整爲16美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Summit Therapeutics with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高利潤的潛力。精明的交易者通過持續的教育、戰略貿易調整、利用各種指標以及隨時關注市場動態來降低這些風險。使用Benzinga Pro了解Summit Therapeutics的最新期權交易，以獲取實時警報。
譯文內容由第三人軟體翻譯。
